Perrigo Company plc (NYSE:PRGO) Plans Quarterly Dividend of $0.29
Perrigo Company plc (NYSE:PRGO) has declared a quarterly dividend of $0.29 per share, payable on March 24, 2026, to shareholders of record on March 2, 2026. This represents an annualized dividend of $1.16 and a dividend yield of 7.8%. The company has a history of consistently increasing its dividend, with 23 consecutive years of raises.
Perrigo Announces Quarterly Dividend
Perrigo Company plc (NYSE: PRGO) has announced that its Board of Directors approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is slated for payment on March 24, 2026, to shareholders recorded by March 2, 2026. Perrigo identifies as a leading pure-play consumer health company, offering high-quality health and wellness solutions primarily in North America and Europe.
Earnings Preview: Perrigo (PRGO) Q4 Earnings Expected to Decline
Perrigo (PRGO) is expected to report a year-over-year decline in Q4 earnings and revenues, with an estimated EPS of $0.80, down 14%, and revenues of $1.1 billion, down 3.2%. The Zacks Earnings ESP is 0%, and with a Zacks Rank #2, it's difficult to conclusively predict an earnings beat despite the company beating consensus EPS estimates in three of the last four quarters. Investors are advised to consider other factors beyond just earnings surprise history.
Consumer health firm Perrigo sets $1.16 annualized payout
Perrigo Company plc announced a quarterly cash dividend of $0.29 per share, totaling an annualized payout of $1.16 per share. This dividend is scheduled to be paid on March 24, 2026, to shareholders of record as of March 2, 2026. The announcement reaffirms Perrigo's focus as a pure-play consumer health company, leveraging its private-label offerings to invest in leading brands.
Perrigo declares quarterly dividend of $0.29 per share
Perrigo Company plc announced a quarterly dividend of $0.29 per share, totaling $1.16 annually, which offers a 7.96% yield. The dividend is payable on March 24, 2026, to shareholders of record by March 2, 2026, continuing the company's 23-year streak of dividend payments. This news follows a recent downgrade in Perrigo's credit rating and revised fiscal guidance due to challenges in the infant nutrition sector.
Perrigo Announces Quarterly Dividend
Perrigo Company plc announced that its Board of Directors has approved a quarterly cash dividend of $0.29 per share, totaling $1.16 per share on an annualized basis. The dividend is payable on March 24, 2026, to shareholders of record as of March 2, 2026. Perrigo identifies itself as a leading pure-play consumer health company focused on providing over-the-counter self-care solutions primarily in North America and Europe.
CenterBook Partners LP Sells 75,898 Shares of Perrigo Company plc $PRGO
CenterBook Partners LP reduced its holdings in Perrigo Company plc by 29.2%, selling 75,898 shares, now owning 184,152 shares valued at $4.10 million. Despite this, other institutional investors like Cooke & Bieler LP, Diamond Hill Capital Management Inc., Nicola Wealth Management LTD., and Sound Income Strategies LLC increased their stakes, bringing institutional ownership to 95.91%. Perrigo currently trades at $14.61 with a market cap of $2.01 billion, and analysts have a consensus "Hold" rating with a $20.33 price target.
Perrigo Company plc (PRGO): Valuation Insights Reveal Significant 44% Upside Potential for Investors
Perrigo Company plc (PRGO) is a healthcare sector player with a market cap of $2 billion, currently trading at $14.54. Despite recent financial challenges, including revenue contraction and negative EPS, the company exhibits a forward P/E of 5.50 and robust free cash flow of $358 million, suggesting undervaluation. Analysts project an average target price of $21.00, implying a 44.43% upside potential, making it an intriguing option for diversified portfolios.
Heartland Advisors Inc. Has $24.16 Million Holdings in Perrigo Company plc $PRGO
Heartland Advisors Inc. significantly increased its stake in Perrigo Company plc (NYSE:PRGO) in Q3, now holding 1,084,778 shares valued at $24.16 million, making it their 8th largest holding. Despite this institutional interest, with 95.9% of the stock owned by institutional investors, analyst sentiment remains weak, with a consensus "Reduce" rating and an average target price significantly higher than the current trading price. The company operates in healthcare, specializing in over-the-counter and self-care products, with its stock currently trading near a 52-week low.
Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
Perrigo Company plc (NYSE: PRGO) announced it will release its fourth quarter and fiscal year 2025 financial results on Thursday, February 26, 2026. The company will host a conference call at 8:30 A.M. (EST) on the same day to discuss the results, which will be accessible via webcast and phone. Perrigo is a leading pure-play consumer health company focused on providing over-the-counter self-care solutions.
Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
Perrigo Company plc announced it will release its fourth quarter and fiscal year 2025 financial results on Thursday, February 26, 2026. The company will also host a conference call at 8:30 AM EST to discuss the results, with a live webcast available on its investor relations website and a replay accessible for a limited time. Perrigo, a leading consumer health company, provides over-the-counter self-care solutions primarily in North America and Europe.
Sound Shore Management Inc CT Boosts Holdings in Perrigo Company plc $PRGO
Sound Shore Management Inc CT increased its stake in Perrigo Company plc (NYSE:PRGO) by 11.1% in the third quarter, bringing its total holdings to 3,650,998 shares valued at $81.3 million. Several other institutional investors also increased or initiated positions in Perrigo, leading to institutional ownership of approximately 95.91%. Despite the increased institutional interest, Wall Street analysts currently have a consensus "Reduce" rating on Perrigo, with an average price target of $20.33.
ProShare Advisors LLC Lowers Stock Holdings in Perrigo Company plc $PRGO
ProShare Advisors LLC decreased its holdings in Perrigo Company plc (NYSE:PRGO) by 6.8% in the third quarter, selling 90,109 shares and ending with 1,237,768 shares valued at approximately $27.57 million. Perrigo's stock has faced downward pressure, trading below its 200-day average, and analysts have issued multiple downgrades, resulting in an average "Reduce" rating and a target price of $20.33. The company, a global healthcare supplier, focuses on OTC and self-care products, with institutional investors owning 95.91% of its stock.
Perrigo Company plc (PRGO) Stock Analysis: Evaluating a 46.65% Upside Potential for Healthcare Investors
Perrigo Company plc (PRGO) is analyzed as an intriguing player in the healthcare sector with a potential upside of 46.65% based on analyst targets. Despite its strong free cash flow and attractive 8.10% dividend yield, the company faces challenges including negative EPS, declining revenue growth, and a highly unsustainable payout ratio. Investors are advised to carefully consider these mixed signals and the stock's overbought RSI before making investment decisions.
Diamond Hill Capital Management Inc. Has $40.04 Million Stake in Perrigo Company plc $PRGO
Diamond Hill Capital Management Inc. has increased its stake in Perrigo Company plc (NYSE:PRGO) by 8.6% in the third quarter, now owning 1,797,746 shares valued at approximately $40.04 million. Despite this increase from an institutional investor, analysts generally hold a "Reduce" rating for PRGO with a consensus price target of $20.33 due to downgrades and price-target cuts. Insider transactions show Director Geoffrey M. Parker recently increased his holdings by purchasing 7,500 shares.
Perrigo Company plc (NYSE:PRGO) Receives Average Rating of "Reduce" from Brokerages
Perrigo Company plc (NYSE:PRGO) has received an average rating of "Reduce" from six brokerage firms, with a consensus 12-month target price of $20.33. This follows mixed financial results, including a slight beat on EPS but a 4.1% decline in revenue year-over-year. Insider activity shows a director purchasing shares, while institutional investors have also adjusted their holdings.
New York State Common Retirement Fund Sells 82,986 Shares of Perrigo Company plc $PRGO
The New York State Common Retirement Fund reduced its stake in Perrigo Company plc by 18.5% in the third quarter, selling 82,986 shares and owning 365,253 shares valued at $8.13 million. Despite this, other institutional investors like Norges Bank, Perpetual Ltd, Ion Asset Management Ltd., Goldman Sachs Group Inc., and State Street Corp increased their positions in the company. Perrigo's stock performance and analyst ratings show a mixed outlook, with a consensus "Reduce" rating and an average price target of $20.33.
Perrigo to Conduct Strategic Review of its Infant Formula Business
Perrigo Company plc has announced a strategic review of its infant formula business, aligning with its 'Three-S' plan to stabilize, streamline, and strengthen its portfolio. This review aims to assess various alternatives, accelerate cash flows, and re-evaluate a $240 million investment in the business, which is expected to generate approximately $360 million in net sales in 2025. President and CEO Patrick Lockwood-Taylor stated that while operations have stabilized, the external environment makes the infant formula business less strategic to its consumer health OTC businesses, emphasizing a sharpened focus on its high-potential OTC portfolio.
Nicola Wealth Management LTD. Has $6.26 Million Stock Position in Perrigo Company plc $PRGO
Nicola Wealth Management LTD. increased its stake in Perrigo Company by 38.4% to 281,000 shares, now valued at $6.26 million. Despite this, analyst ratings for Perrigo are generally negative, with a "Reduce" consensus and an average price target of $20.33. The company faces financial risks as indicated by a negative payout ratio, declining revenue, and a negative net margin, even with an 8.0% dividend yield.
Cooke & Bieler LP Raises Stake in Perrigo Company plc $PRGO
Cooke & Bieler LP increased its stake in Perrigo Company plc by 11.6% in Q3, investing an additional $81.96 million. Despite this, analysts have a "Reduce" consensus rating with a $20.33 price target, and concerns exist about the sustainability of Perrigo's dividend due to a deeply negative payout ratio. Furthermore, insider Director Geoffrey M. Parker purchased 7,500 shares in November, increasing his ownership by 75.95%.
Burned by Perrigo Company plc? Contact Levi & Korsinsky to SueWallSt and Fight Back
Levi & Korsinsky has filed a class action lawsuit against Perrigo Company plc on behalf of investors who suffered losses due to alleged securities fraud between February 27, 2023, and November 4, 2025. Investors are encouraged to contact Levi & Korsinsky for more information on how to participate in the lawsuit and fight back against their losses. The firm, known for securing significant recoveries for aggrieved shareholders, provides details on contacting them via their website, email, or phone.
Perrigo Company Faces Class Action for Misleading Statements
Perrigo Company is facing a class action lawsuit for alleged violations of securities laws, stemming from misleading statements made between February 27 and November 4, 2025. The lawsuit claims Perrigo failed to adequately invest in its baby formula business acquired from Nestlé, leading to misrepresented cost estimates and significant investor losses. The Schall Law Firm is offering free consultations to affected investors.
Bronstein, Gewirtz & Grossman LLC Urges Perrigo Company plc Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Perrigo Company plc (NYSE: PRGO) on behalf of investors who purchased securities between February 27, 2025, and November 4, 2025. The lawsuit alleges that Perrigo failed to disclose significant underinvestment, required substantial capital expenditures, and manufacturing deficiencies in its infant formula business acquired from Nestlé, leading to overstated financial results. Investors who suffered losses are encouraged to join the lawsuit and may seek to be appointed as lead plaintiff by January 16, 2026.
Class Action Filed Against Perrigo Company plc (PRGO) Seeking Recovery for Investors – Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a class action lawsuit against Perrigo Company plc (NYSE: PRGO) on behalf of investors who suffered losses due to alleged securities fraud between February 27, 2023, and November 4, 2025. The lawsuit claims that Perrigo made false statements regarding significant underinvestment and manufacturing deficiencies in its acquired infant formula business, leading to overstated financial results. Investors affected during this period have until January 16, 2026, to request to be appointed as lead plaintiff.
Perrigo Company Securities Class Action Notice, Compensation Deadline January 16, 2026
Rosen Law Firm has issued a securities class action notice for investors who purchased Perrigo (PRGO) securities between February 27, 2023, and November 4, 2025, with a lead plaintiff deadline of January 16, 2026. The lawsuit alleges that Perrigo failed to disclose significant underinvestment and manufacturing deficiencies in its acquired infant formula business, leading to overstated financial results. Wall Street analysts predict a rise in PRGO stock price over the next 12 months, with an average 1-year target of $27.50, despite recent downgrades from firms like JPMorgan and Canaccord due to business uncertainties and slower-than-expected recovery in the infant formula segment.
Perrigo Company plc (NYSE: PRGO) Investor Alert: Deadline in Lawsuit on January 16, 2026
A lawsuit deadline is approaching on January 16, 2026, for investors in Perrigo Company plc (NYSE: PRGO). The suit alleges that Perrigo made false and misleading statements between February 27, 2023, and November 4, 2025, regarding significant underinvestment and manufacturing deficiencies in its acquired infant formula business. Investors who purchased PRGO shares during this period have specific options and are encouraged to contact the Shareholders Foundation.
PRGO Deadline: Rosen Law Firm Urges Perrigo Company plc (NYSE: PRGO) Investors to Contact the Firm for Information About Their Rights
Rosen Law Firm is reminding investors of a class action lawsuit against Perrigo Company plc (NYSE: PRGO) concerning alleged materially false or misleading statements regarding its infant formula business. The lawsuit claims significant underinvestment, required remediation costs, and manufacturing deficiencies in the acquired Nestlé infant formula business led to overstated financial results. Investors who purchased securities between February 27, 2023, and November 4, 2025, are urged to contact the firm, with a lead plaintiff deadline of January 16, 2026.
PRGO Deadline: PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
The Rosen Law Firm is reminding investors who purchased Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Perrigo misrepresented the condition of its infant formula business acquired from Nestlé, citing underinvestment, substantial undisclosed remediation costs, and significant manufacturing deficiencies. Investors are encouraged to contact the firm to potentially lead the class action and seek compensation for their losses.
Bronstein, Gewirtz & Grossman LLC Urges Perrigo Company plc Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Perrigo Company plc (NYSE: PRGO) and certain officers, alleging federal securities law violations. The lawsuit claims Perrigo made false and misleading statements regarding its infant formula business, specifically concerning underinvestment, necessary capital expenditures, and manufacturing deficiencies, which overstated the company's financial results. Investors who purchased Perrigo securities between February 27, 2025, and November 4, 2025, are encouraged to join the suit, with a lead plaintiff deadline of January 16, 2026.
Bronstein, Gewirtz & Grossman LLC Urges Perrigo Company plc
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Perrigo Company plc (NYSE: PRGO) on behalf of investors who purchased securities between February 27, 2025, and November 4, 2025. The lawsuit alleges that Perrigo made false and misleading statements regarding significant underinvestment and manufacturing deficiencies in its infant formula business acquired from Nestlé, leading to overstated financial results. Investors are encouraged to join the case, with a lead plaintiff deadline of January 16, 2026.
Class Action Filed Against Perrigo Company plc (PRGO) Seeking Recovery for Investors – Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a class action lawsuit against Perrigo Company plc (NYSE: PRGO) on behalf of investors who suffered losses due to alleged securities fraud between February 27, 2023, and November 4, 2025. The lawsuit claims Perrigo made false statements regarding significant underinvestment and manufacturing deficiencies in its infant formula business acquired from Nestlé, which led to overstated financial results. Investors have until January 16, 2026, to request appointment as lead plaintiff.
Perrigo Company plc Class Action: The Gross Law Firm Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - PRGO
The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc (NYSE: PRGO) regarding a class action lawsuit. Investors who purchased PRGO shares between February 27, 2023, and November 4, 2025, are encouraged to contact the firm for potential lead plaintiff appointment. The lawsuit alleges that Perrigo issued materially false and misleading statements concerning its infant formula business, specifically regarding underinvestment, required expenditures, and manufacturing deficiencies, leading to overstated financial results.
PERRIGO FINAL CLASS ACTION DEADLINE REMINDER: Bragar Eagel
Bragar Eagel & Squire, P.C. reminds investors in Perrigo Company plc (NYSE: PRGO) of the January 16, 2026, deadline to apply for lead plaintiff in a class action lawsuit. The lawsuit alleges that Perrigo failed to disclose significant underinvestment and manufacturing deficiencies in its infant formula business, causing its stock price to drop after disappointing financial results were announced. Investors who purchased Perrigo securities between February 27, 2023, and November 4, 2025, and suffered losses are encouraged to contact the firm.
PERRIGO FINAL CLASS ACTION DEADLINE REMINDER: Bragar Eagel
Bragar Eagel & Squire, P.C. reminds investors of the upcoming January 16, 2026 deadline to apply for lead plaintiff in a class action lawsuit against Perrigo Company plc (NYSE: PRGO). The lawsuit alleges that Perrigo failed to disclose significant underinvestment and manufacturing deficiencies in its acquired infant formula business, leading to overstated financial results. Investors who purchased Perrigo securities between February 27, 2023, and November 4, 2025, and suffered losses are encouraged to contact the firm.
PRGO DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Perrigo Company plc Investors to Join the Class Action Lawsuit Today
Bronstein, Gewirtz & Grossman, LLC reminds investors of Perrigo Company plc (NYSE:PRGO) to join a class action lawsuit filed against the company and its officers. The lawsuit alleges that Perrigo made materially false and misleading statements regarding its acquired infant formula business, failing to disclose significant underinvestment, required capital expenditures, and manufacturing deficiencies. Investors who purchased Perrigo securities between February 27, 2025, and November 4, 2025, have until January 16, 2026, to request to be appointed as lead plaintiff.
PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding Perrigo Company plc (NYSE: PRGO) investors of a class action lawsuit for alleged securities fraud between February 27, 2025, and November 4, 2025. The lawsuit claims Perrigo made false and misleading statements regarding underinvestment in their acquired baby formula business, which required significant unannounced expenditures. Investors who suffered losses during this period are encouraged to contact the firm by January 16, 2026, to discuss their rights.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of January 16, 2026 in Perrigo Company plc Lawsuit – PRGO
The Gross Law Firm is reminding shareholders of Perrigo Company plc (NYSE: PRGO) who purchased shares between February 27, 2023, and November 4, 2025, about a lead plaintiff deadline of January 16, 2026. The lawsuit alleges that Perrigo issued misleading statements regarding significant underinvestment and manufacturing deficiencies in its infant formula business acquired from Nestlé, leading to overstated financial results. Shareholders are encouraged to register to participate in the class action lawsuit.
Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who
Glancy Prongay & Murray LLP is urging shareholders of Perrigo Company plc (PRGO) who incurred losses to contact them regarding a securities fraud lawsuit. The lawsuit alleges that Perrigo made misleading statements and failed to disclose critical information concerning its infant formula business acquired from Nestlé, leading to significant financial losses for investors. A deadline of January 16, 2026, has been set for investors to file a lead plaintiff motion in the class action.
Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP is urging shareholders of Perrigo Company plc (PRGO) who incurred losses to come forward as the deadline to file a lead plaintiff motion in a securities fraud class action lawsuit approaches on January 16, 2026. The lawsuit alleges that Perrigo made materially false and/or misleading statements regarding its infant formula business, acquired from Nestlé, and failed to disclose chronic underinvestment and manufacturing deficiencies, leading to significant financial misstatements and investor losses. The company's stock price experienced several drops following revelations of remediation costs, production issues, and a revised financial outlook related to the infant formula segment.
Portnoy Law Firm Announces Class Action on Behalf of Perrigo Company plc Investors
The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Perrigo Company plc (NYSE: PRGO) who purchased securities between February 27, 2023, and November 4, 2025. Investors have until January 16, 2026, to file a lead plaintiff motion. This action follows a significant drop in Perrigo's stock price after the company announced a strategic review of its infant formula business, potentially re-evaluating a $240 million investment.
Portnoy Law Firm Announces Class Action on Behalf of Perrigo Company plc Investors
The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Perrigo Company plc (NYSE: PRGO) who purchased securities between February 27, 2023, and November 4, 2025. This action follows a significant drop in Perrigo's stock price after the company announced a strategic review of its infant formula business, including a reassessment of a $240 million investment. Investors have until January 16, 2026, to file a lead plaintiff motion to recover their losses.
Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP is alerting investors of Perrigo Company plc (NYSE: PRGO) about an upcoming deadline to file a lead plaintiff motion in a class action lawsuit. The lawsuit alleges that Perrigo and its executives made misleading statements regarding the infant formula business acquired from Nestlé, failing to disclose significant underinvestment and manufacturing deficiencies which led to financial overstatements. Investors who suffered losses on Perrigo securities between February 27, 2023, and November 4, 2025, are encouraged to contact the law firm for more information.
State of Alaska Department of Revenue Grows Stock Position in Perrigo Company plc $PRGO
The State of Alaska Department of Revenue significantly increased its stake in Perrigo Company plc (NYSE:PRGO) by 695.7% in Q3, now holding 122,855 shares valued at approximately $2.74 million. This move coincides with director Geoffrey M. Parker's purchase of 7,500 shares. Despite the increased institutional and insider buying, analysts maintain a "Reduce" consensus rating with an average price target of $20.33, though the company offers a substantial 7.7% dividend yield.
PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding investors of a class action lawsuit against Perrigo Company plc (NYSE: PRGO) for alleged securities fraud. The lawsuit claims Perrigo made false and misleading statements regarding its baby formula business, which purportedly required significant investments beyond what was disclosed. Investors who purchased securities between February 27, 2025, and November 4, 2025, are encouraged to contact the firm before January 16, 2026.
Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Glancy Prongay & Murray LLP has announced a securities fraud class action lawsuit against Perrigo Company plc (PRGO). The lawsuit, with a lead plaintiff deadline of January 16, 2026, alleges that Perrigo misrepresented the condition of its infant formula business acquired from Nestlé, failing to disclose significant underinvestment, required capital expenditures, and manufacturing deficiencies. Investors who suffered losses on their Perrigo investments between February 27, 2023, and November 4, 2025, are encouraged to participate.
Portnoy Law Firm Announces Class Action on Behalf of Perrigo Company plc Investors
The Portnoy Law Firm has announced a class action lawsuit against Perrigo Company plc (NYSE: PRGO) on behalf of investors who purchased securities between February 27, 2023, and November 4, 2025. This action follows a significant drop in Perrigo's stock price after the company announced a strategic review of its infant formula business, including a reassessment of a $240 million investment. Investors have until January 16, 2026, to file a lead plaintiff motion.
Bronstein, Gewirtz & Grossman LLC Urges Perrigo Company plc
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Perrigo Company plc (NYSE: PRGO), alleging securities law violations and investor harm. The lawsuit claims that Perrigo made materially false and misleading statements regarding significant underinvestment, required capital expenditures, and manufacturing deficiencies in its acquired infant formula business. Investors who purchased Perrigo securities between February 27, 2025, and November 4, 2025, are encouraged to join the case, with a lead plaintiff deadline of January 16, 2026.
PRGO Deadline: PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
The Rosen Law Firm is reminding purchasers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023, and November 4, 2025, that the lead plaintiff deadline for a securities fraud lawsuit is January 16, 2026. The lawsuit alleges that Perrigo made materially false and misleading statements regarding significant underinvestment and manufacturing deficiencies in its acquired infant formula business, leading to overstated financial results. Investors who bought Perrigo securities during this period may be entitled to compensation and are encouraged to contact the law firm to join the class action.
PERRIGO (PRGO) CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Perrigo Company plc Investors of the Upcoming January 16th Deadline and Urges Investors to Contact the Firm
Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Perrigo Company plc (NYSE: PRGO) on behalf of investors who purchased securities between February 27, 2023, and November 4, 2025. The lawsuit alleges that Perrigo failed to disclose significant underinvestment and manufacturing deficiencies in its infant formula business, leading to overstated financial results. Investors have until January 16, 2026, to apply to be appointed as lead plaintiff.
PERRIGO (PRGO) CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Perrigo Company plc ...
Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Perrigo Company plc (PRGO) on behalf of investors who purchased securities between February 27, 2023, and November 4, 2025. The lawsuit alleges that Perrigo failed to disclose significant underinvestment in its infant formula business, requiring substantial capital expenditures and leading to overstated financial results. Perrigo's stock price dropped significantly after the company announced disappointing financial results and a strategic review of its infant formula business due to industry dynamics.
